Autografting in chronic myelogenous leukemia: New questions

A. M. Carella, F. Frassoni, R. S. Negrin

Research output: Contribution to journalArticle

Abstract

In the 1970s, when autografting was started, it was hard to imagine that this procedure would have an application in hematological malignancies. Autografting in patients with CML has been difficult to pursue because their bone marrow is often contaminated by Philadelphia-chromosome positive cells. In recent years, renewed interest has come from this procedure and various in vivo or in vitro techniques of manipulation of Ph-positive cells, such as collection of blood progenitor cells in the early phase of recovery after intensive conventional chemotherapy in untreated or pretreated patients, long-term bone marrow culture and chemical purging of marrow cells. Despite all these interesting trials, we do not have enough data to address the question of whether autografting in CML increases the duration of the chronic phase.

Original languageEnglish
Pages (from-to)365-369
Number of pages5
JournalLeukemia
Volume9
Issue number3
Publication statusPublished - 1995

Fingerprint

Autologous Transplantation
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Bone Marrow
Philadelphia Chromosome
Hematologic Neoplasms
Blood Cells
Stem Cells
Drug Therapy

ASJC Scopus subject areas

  • Cancer Research
  • Hematology

Cite this

Autografting in chronic myelogenous leukemia : New questions. / Carella, A. M.; Frassoni, F.; Negrin, R. S.

In: Leukemia, Vol. 9, No. 3, 1995, p. 365-369.

Research output: Contribution to journalArticle

@article{0f02005f468a4cbcadbeda484912cf59,
title = "Autografting in chronic myelogenous leukemia: New questions",
abstract = "In the 1970s, when autografting was started, it was hard to imagine that this procedure would have an application in hematological malignancies. Autografting in patients with CML has been difficult to pursue because their bone marrow is often contaminated by Philadelphia-chromosome positive cells. In recent years, renewed interest has come from this procedure and various in vivo or in vitro techniques of manipulation of Ph-positive cells, such as collection of blood progenitor cells in the early phase of recovery after intensive conventional chemotherapy in untreated or pretreated patients, long-term bone marrow culture and chemical purging of marrow cells. Despite all these interesting trials, we do not have enough data to address the question of whether autografting in CML increases the duration of the chronic phase.",
author = "Carella, {A. M.} and F. Frassoni and Negrin, {R. S.}",
year = "1995",
language = "English",
volume = "9",
pages = "365--369",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Autografting in chronic myelogenous leukemia

T2 - New questions

AU - Carella, A. M.

AU - Frassoni, F.

AU - Negrin, R. S.

PY - 1995

Y1 - 1995

N2 - In the 1970s, when autografting was started, it was hard to imagine that this procedure would have an application in hematological malignancies. Autografting in patients with CML has been difficult to pursue because their bone marrow is often contaminated by Philadelphia-chromosome positive cells. In recent years, renewed interest has come from this procedure and various in vivo or in vitro techniques of manipulation of Ph-positive cells, such as collection of blood progenitor cells in the early phase of recovery after intensive conventional chemotherapy in untreated or pretreated patients, long-term bone marrow culture and chemical purging of marrow cells. Despite all these interesting trials, we do not have enough data to address the question of whether autografting in CML increases the duration of the chronic phase.

AB - In the 1970s, when autografting was started, it was hard to imagine that this procedure would have an application in hematological malignancies. Autografting in patients with CML has been difficult to pursue because their bone marrow is often contaminated by Philadelphia-chromosome positive cells. In recent years, renewed interest has come from this procedure and various in vivo or in vitro techniques of manipulation of Ph-positive cells, such as collection of blood progenitor cells in the early phase of recovery after intensive conventional chemotherapy in untreated or pretreated patients, long-term bone marrow culture and chemical purging of marrow cells. Despite all these interesting trials, we do not have enough data to address the question of whether autografting in CML increases the duration of the chronic phase.

UR - http://www.scopus.com/inward/record.url?scp=0028912492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028912492&partnerID=8YFLogxK

M3 - Article

C2 - 7885034

AN - SCOPUS:0028912492

VL - 9

SP - 365

EP - 369

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 3

ER -